Ah, yes. You see, I thought there might be some of that $75m...

Ah, yes.

You see, I thought there might be some of that $75m from the 3 October 2019 capital raising left over, given that almost 4 months of raising that capital, I could not find any sign of it being actually converted into inventory build (unless they account for it off-balance sheet, for some reason):



Can you identify an item that resembles Inventory on that statement of position?


And since that balance date, there has been a total of ~$2.7m allocated to manufacturing commercialisation and product manufacturing & operating costs (and clearly not all of that $2.7m would have translated into inventory of that value, assuming it is carried at cost):



So the inventory build for paediatric SR aGvHD is not exactly running a-pace from what I can see in the published, audited information

I'm obviously missing something....

.